Angiotensin Receptor-Neprilysin Inhibition Therapy and Improved Exercise Parameters in Heart Failure with Reduced Ejection Fraction

Arq Bras Cardiol. 2020 Nov;115(5):828-829. doi: 10.36660/abc.20200566.
[Article in English, Portuguese]
No abstract available

Publication types

  • Editorial
  • Comment

MeSH terms

  • Aminobutyrates / therapeutic use
  • Angiotensins
  • Biphenyl Compounds
  • Drug Combinations
  • Heart Failure* / drug therapy
  • Humans
  • Neprilysin*
  • Oxygen
  • Receptors, Angiotensin
  • Stroke Volume
  • Tetrazoles
  • Valsartan

Substances

  • Aminobutyrates
  • Angiotensins
  • Biphenyl Compounds
  • Drug Combinations
  • Receptors, Angiotensin
  • Tetrazoles
  • Valsartan
  • Neprilysin
  • Oxygen
  • sacubitril and valsartan sodium hydrate drug combination